New York Clinical Trial Quietly Tests Heartburn Remedy Against

New York Clinical Trial Quietly Tests Heartburn Remedy Against Coronavirus . The fast-growing list of possible treatments for the novel coronavirus includes an unlikely candidate: famotidine, the active compound in the over-the-counter heartburn drug Pepcid. On 7 April, the

Can You Teach Old Drugs New Tricks?

Zantac Cancer Risk Data Was Kept Quiet by Manufacturer Glaxo for

Patient Communication and Patient Centered Care

Comparison of lumiracoxib with naproxen and ibuprofen in the

Georgetown Medicine Spring/Summer 2016 by Georgetown University

Cyclic Vomiting Syndrome - Symptoms, Causes, Treatment

Heartburn Pill in Short Supply After Word of Covid-19 Trial

Common Heartburn Drug Being Studied As Possible COVID-19 Treatment

Randomized Trial of Medical versus Surgical Treatment for

Could a common heartburn drug treat COVID-19? One hospital system

Books of Interest - IFFGD

Brendan Borrell Pulitzer Center

Coronavirus treatment: NY hospitals quietly testing heartburn drug

5 notable Northwell advances of 2022

Laryngopharyngeal Reflux: Position Statement of the Committee on